🔎 Trials Near Me

Hem › Major depression › New York › New York City

Kliniska studier för Major depression i New York City, NY

36 studier för Major depression söker deltagare vid platser i och runt New York City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

RekryterarFas 3
  • Adams Clinical Harlem, New York
  • New York State Psychiatric Institute, New York
Ålder 18 till 85 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06793397

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

RekryterarFas 3
  • Adams Clinical Harlem, New York
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT07412756

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

RekryterarFas 3
  • Fieve Clinical Research Inc, New York
  • Adams Clinical Harlem, New York
  • Manhattan Behavioral Medicine, New York
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07573176

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

RekryterarFas 3
  • Manhattan Behavioral Medicine, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RekryterarFas 3
  • Fieve Clinical Research Inc, New York
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

RekryterarFas 2
  • Ima Clinical Research - Nyc Midtown, New York
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07621237

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

RekryterarFas 3
  • Vanda Investigational Site, New York
  • Vanda Investigational Site, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06830044

DBS for TRD With the Medtronic Percept PC

Rekryterar
  • Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Ålder 25 till 70 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05773755

Pattern Separation in Major Depressive Disorder

RekryterarFas 1
  • New York State Psychiatric Institute (NYSPI), New York
Ålder 18 till 50 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07139834

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

RekryterarFas 2
  • Seaport Investigator Site, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

RekryterarFas 3
  • Fieve Clinical Research, Inc., New York
  • IMA Clinical Research, New York
Ålder 18 till 74 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

RekryterarFas 2
  • Draig Clinical Site, New York
  • Draig Clinical Site, New York
Ålder 18 till 75 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Rekryterar
  • Mount Sinai Hospital, New York
Ålder 22 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

RekryterarFas 2
  • Draig Clinical Site, New York
Ålder 18 till 75 · Alla kön · Uppdaterad 26 aug. 2026 · NCT07300969

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, New York
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT06911112

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, New York
Ålder 18 och äldre · Alla kön · Uppdaterad 10 aug. 2026 · NCT06963021

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RekryterarFas 2
  • IMA Clinical Research - NYC Midtown, New York
  • IMA Clinical Research - NYC Uptown, New York
Ålder 18 till 64 · Alla kön · Uppdaterad 27 juli 2026 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

RekryterarFas 3
  • Clinical Research Site, New York
  • Clinical Research Site, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 24 juli 2026 · NCT07484217

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, New York
  • Neurocrine Clinical Site, New York
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

Rekryterar
  • NYU Langone Health, New York
Ålder 24 till 65 · Alla kön · Uppdaterad 29 juni 2026 · NCT07111390

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RekryterarFas 2
  • Ima Clinical Research - Manhattan /ID# 278212, New York
  • Manhattan Behavioral Medicine /ID# 277910, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 15 juni 2026 · NCT07276997

tDCS: Sleep to Mood in Depression (S2M-D)

Rekryterar
  • NYU Langone Health, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 8 juni 2026 · NCT07572526

Triage Survey for Psychiatry Research Eligibility

RekryterarObservationsstudie
  • Adams Clinical, Harlem, New York
Ålder 18 och äldre · Alla kön · Uppdaterad 20 maj 2026 · NCT05800925

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

RekryterarFas 2
  • The Medical Research Network, LLC, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 11 maj 2026 · NCT06524830

Aβ Dynamics in LLMD

RekryterarFas 4
  • NYU Langone Health, New York
Ålder 60 och äldre · Alla kön · Uppdaterad 6 maj 2026 · NCT05004987

Maintenance rTMS for Depression (Maitr-De)

Rekryterar
  • Weill Cornell Medicine, New York
Ålder 18 till 80 · Alla kön · Uppdaterad 29 apr. 2026 · NCT06938841

Neutralizing Interleukin (IL)-6

RekryterarFas 2Friska volontärer välkomna
  • Icahn School of Medicine at Mount Sinai, New York
Ålder 18 till 70 · Alla kön · Uppdaterad 29 apr. 2026 · NCT07493317

Mindfulness-Based fMRI Neurofeedback for Depression

Rekryterar
  • Columbia University Irving Medical Center, New York
Ålder 13 till 18 · Alla kön · Uppdaterad 29 apr. 2026 · NCT05617495

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Rekryterar
  • Weill Cornell Medicine, New York
Ålder 50 till 80 · Alla kön · Uppdaterad 27 mars 2026 · NCT05925322

Biomarker-guided rTMS for Treatment Resistant Depression

RekryterarFas 3
  • Weill Cornell Medicine, New York
Ålder 22 till 65 · Alla kön · Uppdaterad 25 feb. 2026 · NCT04041479

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

Rekryterar
  • NYU Langone Health, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 5 feb. 2026 · NCT05573074

Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients

Rekryterar
  • Icahn School of Medicine at Mount Sinai, New York
Ålder 18 till 80 · Alla kön · Uppdaterad 25 sep. 2025 · NCT05239780

Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

RekryterarFas 2
  • Icahn School of Medicine at Mount Sinai, New York
Ålder 18 till 90 · Alla kön · Uppdaterad 15 juli 2025 · NCT06559826

Neural Circuit Effects of Ketamine in Depression

RekryterarFas 4Friska volontärer välkomna
  • Icahn School of Medicine at Mount Sinai, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 3 juli 2025 · NCT06213324

Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder

RekryterarFas 2
  • Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York
Ålder 21 till 80 · Alla kön · Uppdaterad 14 maj 2025 · NCT06592833

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RekryterarFas 4
  • Clinical Research Site, New York
Ålder 18 till 65 · Alla kön · Uppdaterad 23 jan. 2025 · NCT06223880

Major depression-studier i andra städer

Andra studier i New York City

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.